Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lateef Fund Class A (LIMAX)

13.35
Net Asset Value
-2.91%
1 Day
-4.30%
Year-to-Date
Overall Morningstar Rating
Large growth
Style or Category
5
Sales Expenses
1.41%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide principal preservation and long-term capital appreciation. The fund normally invests in the common stocks of approximately 15 to 25 mid- and large-cap companies (market capitalizations greater than $2 billion) with, in the Adviser's opinion, a sustainable competitive advantage. The Adviser uses an intensive fundamental due diligence research process to attempt to identify companies with owner-oriented management teams that, in the view of the Adviser, generate consistent and sustainable high returns on capital. It is non-diversified.

Performance

1 month-11.00% 3 years+11.16%
3 months-6.90% 5 years+13.46%
1 year-1.93% Since inception+7.58%
Data through --

Peer Comparisonvs. Large growth

 LIMAXCategory
Performance 5-yr return+13.46%+16.96%
Expense ratio1.41%1.20%
Risk 5 year sharpe ratio1.121.19
Net assets$771.7M$2.8B
Average market cap$23.8B$81.2B
Average P/E25.223.1
Portfolio turnover29%29%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyLateef Investment Management, L.p.
Fund manager & tenureQuoc Tran / 7 Years
Minimal initial investment$5,000.00
Minimum IRA investment$2,500.00

Holdings

U.S. stock91.89%
Cash8.11%
International stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Financial service 31.63%
Business service 17.30%
Hardware 13.88%
Telecommunication 8.11%
Energy 7.91%
Top 10 Holdings
Portfolio weighting
AME Ametek Inc7.74%
TW Towers Watson & Co6.80%
CELG Celgene6.37%
WAB Westinghouse Air Brake Technologies Corp5.64%
FB Facebook5.45%
AON Aon PLC5.36%
NLSN Nielsen NV5.29%
IMS IMS Health Holdings Inc5.28%
SWK Stanley Black & Decker Inc5.26%
DHR Danaher Corp5.12%

Partner Offers